Waters Return on Tangible Equity 2010-2025 | WAT
Current and historical return on tangible equity values for Waters (WAT) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Waters Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-06-30 | $0.66B | $0.24B | 17626.67% |
| 2025-03-31 | $0.66B | $0.10B | -370.14% |
| 2024-12-31 | $0.64B | $-0.04B | -174.32% |
| 2024-09-30 | $0.62B | $-0.30B | -112.61% |
| 2024-06-30 | $0.60B | $-0.48B | -80.76% |
| 2024-03-31 | $0.60B | $-0.65B | -65.97% |
| 2023-12-31 | $0.64B | $-0.78B | -83.64% |
| 2023-09-30 | $0.65B | $-1.03B | -107.04% |
| 2023-06-30 | $0.68B | $-1.19B | -162.85% |
| 2023-03-31 | $0.69B | $-0.07B | -379.09% |
| 2022-12-31 | $0.71B | $-0.15B | -295.31% |
| 2022-09-30 | $0.70B | $-0.25B | -249.15% |
| 2022-06-30 | $0.70B | $-0.26B | -223.03% |
| 2022-03-31 | $0.70B | $-0.30B | -198.87% |
| 2021-12-31 | $0.69B | $-0.31B | -176.64% |
| 2021-09-30 | $0.69B | $-0.39B | -160.93% |
| 2021-06-30 | $0.66B | $-0.42B | -127.85% |
| 2021-03-31 | $0.62B | $-0.45B | -97.97% |
| 2020-12-31 | $0.52B | $-0.47B | -67.97% |
| 2020-09-30 | $0.51B | $-0.73B | -59.17% |
| 2020-06-30 | $0.52B | $-0.87B | -65.28% |
| 2020-03-31 | $0.54B | $-1.01B | -91.87% |
| 2019-12-31 | $0.59B | $-0.81B | -245.39% |
| 2019-09-30 | $0.58B | $-0.48B | 283.39% |
| 2019-06-30 | $0.58B | $-0.04B | 90.65% |
| 2019-03-31 | $0.59B | $0.37B | 59.13% |
| 2018-12-31 | $0.59B | $0.97B | 46.13% |
| 2018-09-30 | $0.06B | $1.27B | 3.84% |
| 2018-06-30 | $0.05B | $1.40B | 3.09% |
| 2018-03-31 | $0.03B | $1.52B | 1.51% |
| 2017-12-31 | $0.02B | $1.65B | 1.13% |
| 2017-09-30 | $0.55B | $2.05B | 28.99% |
| 2017-06-30 | $0.54B | $1.94B | 29.85% |
| 2017-03-31 | $0.53B | $1.83B | 31.20% |
| 2016-12-31 | $0.52B | $1.74B | 31.94% |
| 2016-09-30 | $0.50B | $1.68B | 31.80% |
| 2016-06-30 | $0.49B | $1.58B | 32.72% |
| 2016-03-31 | $0.47B | $1.52B | 32.46% |
| 2015-12-31 | $0.47B | $1.48B | 33.91% |
| 2015-09-30 | $0.47B | $1.39B | 35.01% |
| 2015-06-30 | $0.47B | $1.36B | 35.80% |
| 2015-03-31 | $0.46B | $1.30B | 35.82% |
| 2014-12-31 | $0.43B | $1.31B | 34.26% |
| 2014-09-30 | $0.42B | $1.24B | 34.48% |
| 2014-06-30 | $0.41B | $1.25B | 34.63% |
| 2014-03-31 | $0.40B | $1.23B | 35.99% |
| 2013-12-31 | $0.45B | $1.17B | 43.35% |
| 2013-09-30 | $0.48B | $1.05B | 49.54% |
| 2013-06-30 | $0.49B | $0.99B | 52.98% |
| 2013-03-31 | $0.49B | $0.95B | 57.54% |
| 2012-12-31 | $0.46B | $0.93B | 56.67% |
| 2012-09-30 | $0.42B | $0.80B | 55.13% |
| 2012-06-30 | $0.43B | $0.76B | 57.98% |
| 2012-03-31 | $0.43B | $0.77B | 58.67% |
| 2011-12-31 | $0.43B | $0.74B | 61.63% |
| 2011-09-30 | $0.42B | $0.66B | 63.41% |
| 2011-06-30 | $0.42B | $0.74B | 68.03% |
| 2011-03-31 | $0.40B | $0.67B | 77.83% |
| 2010-12-31 | $0.38B | $0.60B | 88.20% |
| 2010-09-30 | $0.36B | $0.45B | 95.05% |
| 2010-06-30 | $0.34B | $0.35B | 99.34% |
| 2010-03-31 | $0.33B | $0.34B | 101.64% |
| 2009-12-31 | $0.32B | $0.37B | 112.84% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $17.988B | $2.958B |
| Waters Corp. is an analytical instrument manufacturer and offers practical and sustainable products for laboratory-dependent organizations. Moreover, Waters provides analytical workflow solutions based on mass spectrometry (MS), liquid chromatography (LC) and thermal analysis technologies. The company's products are used by pharmaceutical, life science, biochemical, industrial, academic and government customers, working in research and development, quality assurance and other laboratory applications. The company operates in Asia, Americas and Europe. Waters organizes its business into two operating segments: Waters Division and TA Division. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $188.802B | 22.84 |
| Intuitive Surgical (ISRG) | United States | $170.692B | 70.75 |
| IDEXX Laboratories (IDXX) | United States | $51.647B | 53.75 |
| Edwards Lifesciences (EW) | United States | $48.042B | 31.84 |
| Alcon (ALC) | Switzerland | $40.456B | 27.16 |
| IQVIA Holdings (IQV) | United States | $32.496B | 18.36 |
| DexCom (DXCM) | United States | $32.259B | 48.39 |
| Mettler-Toledo (MTD) | United States | $27.221B | 32.31 |
| STERIS (STE) | Ireland | $24.807B | 26.40 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.319B | 0.00 |
| Hologic (HOLX) | United States | $15.182B | 16.45 |
| Penumbra (PEN) | United States | $10.325B | 75.42 |
| Globus Medical (GMED) | United States | $8.444B | 19.48 |
| Sysmex ADR (SSMXY) | Japan | $8.410B | 26.72 |
| Masimo (MASI) | United States | $8.074B | 27.17 |
| Teleflex (TFX) | United States | $5.719B | 9.23 |
| Glaukos (GKOS) | United States | $5.400B | 0.00 |
| TransMedics (TMDX) | United States | $4.086B | 62.10 |
| Integer Holdings (ITGR) | United States | $3.874B | 19.33 |
| LivaNova (LIVN) | United Kingdom | $3.052B | 17.47 |
| Veracyte (VCYT) | United States | $2.439B | 33.70 |
| Alphatec Holdings (ATEC) | United States | $2.388B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $2.294B | 0.00 |
| Artivion (AORT) | United States | $2.115B | 106.74 |
| Elekta AB (EKTAY) | Sweden | $1.924B | 18.00 |
| Nihon Kohden (NHNKY) | Japan | $1.914B | 22.85 |
| Integra LifeSciences Holdings (IART) | United States | $1.158B | 6.63 |
| Pulse Biosciences (PLSE) | United States | $1.147B | 0.00 |
| OPKO Health (OPK) | United States | $1.119B | 0.00 |
| IRadimed (IRMD) | United States | $0.924B | 44.85 |
| Tandem Diabetes Care (TNDM) | United States | $0.806B | 0.00 |
| AxoGen (AXGN) | United States | $0.748B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.741B | 0.00 |
| SiBone (SIBN) | United States | $0.707B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.575B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.543B | 9.60 |
| OrthoPediatrics (KIDS) | United States | $0.506B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.486B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.465B | 3.74 |
| Pacific Biosciences Of California (PACB) | United States | $0.415B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.401B | 10.20 |
| Delcath Systems (DCTH) | United States | $0.389B | 92.67 |
| AngioDynamics (ANGO) | United States | $0.384B | 0.00 |
| RxSight (RXST) | United States | $0.380B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.304B | 0.00 |
| NeuroPace (NPCE) | United States | $0.297B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.295B | 20.35 |
| Spectral Diagnostics (EDTXF) | Canada | $0.289B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.268B | 0.00 |
| 908 Devices (MASS) | United States | $0.231B | 0.00 |
| Neuronetics (STIM) | United States | $0.225B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.222B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.221B | 0.00 |
| Inogen (INGN) | United States | $0.210B | 0.00 |
| CVRx (CVRX) | United States | $0.204B | 0.00 |
| Accuray (ARAY) | United States | $0.179B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.175B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.163B | 0.00 |
| LENSAR (LNSR) | United States | $0.154B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.150B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.126B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.119B | 0.00 |
| Hyperfine (HYPR) | United States | $0.102B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.100B | 0.00 |
| InspireMD (NSPR) | United States | $0.099B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.082B | 0.00 | |
| QT Imaging Holdings (QTIH) | United States | $0.061B | 0.00 |
| Spectral AI (MDAI) | United States | $0.056B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.053B | 0.00 |
| Positron (POSC) | United States | $0.051B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.050B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.044B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.040B | 0.00 |
| Precision Optics (POCI) | United States | $0.038B | 0.00 |
| DarioHealth (DRIO) | United States | $0.026B | 0.00 |
| Envoy Medical (COCH) | United States | $0.025B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.019B | 0.00 |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.015B | 0.00 |
| Tenon Medical (TNON) | United States | $0.013B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.009B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.007B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 13.55 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |